Nicotine therapeutic benefits: Difference between revisions
Jump to navigation
Jump to search
Richardpruen (talk | contribs) (added a covid study) |
|||
| Line 506: | Line 506: | ||
='''COVID'''= | ='''COVID'''= | ||
=== 2023: [https://pubmed.ncbi.nlm.nih.gov/37264452/ The controversial effect of smoking and nicotine in SARS-CoV-2 infection.] === | |||
* States the obvious: the exposure (smoke vs. nicotine and dose need to be characterised correctly). | |||
* Considering that the effects of nicotine and cigarette smoke are different from each other, it is necessary to be careful in generalizing the effects of nicotine and cigarette to each other in the conducted researches. The generalization and the undifferentiation of nicotine from smoke is a significant bias. Moreover, different doses of nicotine stimulate different effects (dose-dependent response). In addition to further assessing the role of nicotine in COVID-19 infection and any other cases, a clever assessment of underlying diseases should also be considered to achieve a guideline for health providers and a personalized approach to treatment. | |||
* Salehi Z, Motlagh Ghoochani BFN, Hasani Nourian Y, Jamalkandi SA, Ghanei M. Allergy Asthma Clin Immunol. 2023 Jun 1;19(1):49. doi: 10.1186/s13223-023-00797-0. PMID: 37264452 Review. | |||
=== 2023: [https://pubmed.ncbi.nlm.nih.gov/36650574/ Is the post-COVID-19 syndrome a severe impairment of acetylcholine-orchestrated neuromodulation that responds to nicotine administration?] === | === 2023: [https://pubmed.ncbi.nlm.nih.gov/36650574/ Is the post-COVID-19 syndrome a severe impairment of acetylcholine-orchestrated neuromodulation that responds to nicotine administration?] === | ||